SRSF3 and triple-negative breast carcinoma: SRSF3 increases the inclusion of exon v8-v10 of CD44 to produce oncogenic isoform CD44E in gastric cancer 146 and promotes the inclusion of variable exons of CD44 isoforms in triple-negative breast cancer (TNBC) 147.